State Street’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $328K | Buy |
97,335
+18,800
| +24% | +$63.4K | ﹤0.01% | 3711 |
|
2025
Q1 | $119K | Hold |
78,535
| – | – | ﹤0.01% | 3934 |
|
2024
Q4 | $173K | Buy |
78,535
+9,300
| +13% | +$20.5K | ﹤0.01% | 3883 |
|
2024
Q3 | $172K | Hold |
69,235
| – | – | ﹤0.01% | 3854 |
|
2024
Q2 | $88.6K | Sell |
69,235
-307,661
| -82% | -$394K | ﹤0.01% | 4042 |
|
2024
Q1 | $1.09M | Buy |
376,896
+3,234
| +0.9% | +$9.35K | ﹤0.01% | 3446 |
|
2023
Q4 | $2.75M | Buy |
373,662
+12,366
| +3% | +$90.9K | ﹤0.01% | 3201 |
|
2023
Q3 | $2.77M | Buy |
361,296
+27,674
| +8% | +$213K | ﹤0.01% | 3187 |
|
2023
Q2 | $3.38M | Buy |
333,622
+279,887
| +521% | +$2.84M | ﹤0.01% | 3183 |
|
2023
Q1 | $522K | Sell |
53,735
-300
| -0.6% | -$2.91K | ﹤0.01% | 3733 |
|
2022
Q4 | $262K | Buy |
54,035
+24,900
| +85% | +$121K | ﹤0.01% | 4008 |
|
2022
Q3 | $417K | Buy |
29,135
+4,100
| +16% | +$58.7K | ﹤0.01% | 3848 |
|
2022
Q2 | $135K | Sell |
25,035
-151,445
| -86% | -$817K | ﹤0.01% | 4376 |
|
2022
Q1 | $1.14M | Buy |
176,480
+56,539
| +47% | +$366K | ﹤0.01% | 3768 |
|
2021
Q4 | $1.94M | Buy |
119,941
+18,739
| +19% | +$303K | ﹤0.01% | 3645 |
|
2021
Q3 | $2.69M | Buy |
+101,202
| New | +$2.69M | ﹤0.01% | 3529 |
|